Literature DB >> 24900396

5-Amino-oxazepine and 5-Amino-thiazepine Compounds as β-Secretase Antagonists and Methods of Use: Patent Highlight.

Benjamin Blass1.   

Abstract

Entities:  

Year:  2012        PMID： 24900396      PMCID： PMC4025755          DOI： 10.1021/ml300323y

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

1.  The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing.

Authors:  Hank F Kung
Journal:  ACS Med Chem Lett       Date:  2012-03-12       Impact factor: 4.345

Review 2.  BACE inhibitors as potential drugs for the treatment of Alzheimer's disease: focus on bioactivity.

Authors:  Genevieve Evin; Guillaume Lessene; Simon Wilkins
Journal:  Recent Pat CNS Drug Discov       Date:  2011-05-01

Review 3.  Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011).

Authors:  Gary Probst; Ying-zi Xu
Journal:  Expert Opin Ther Pat       Date:  2012-04-19       Impact factor: 6.674

Review 4.  Β-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis.

Authors:  Jiangli Tan; Geneviève Evin
Journal:  J Neurochem       Date:  2012-01-23       Impact factor: 5.372
  4 in total
  1 in total

Review 1.  Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment.

Authors:  Judite R M Coimbra; Daniela F F Marques; Salete J Baptista; Cláudia M F Pereira; Paula I Moreira; Teresa C P Dinis; Armanda E Santos; Jorge A R Salvador
Journal:  Front Chem       Date:  2018-05-24       Impact factor: 5.221
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.